Radionuclide operating table capable of displaying radioactive contamination

Abstract

The invention discloses a radionuclide operation table capable of displaying radioactive contamination. The radionuclide operation table capable of displaying radioactive contamination comprises a supporting assembly, a separating assembly, a first color developing assembly and a second color developing assembly, wherein the supporting assembly comprises a box body, a lifting mechanism, a bearingplate and rolling wheels; the separating assembly comprises a supporting frame, a separating plate, an injection box and an observation window; the first color developing assembly comprises a hook-and-loop fastener, a flexible pad, a waterproof breathable film layer, an adhesive layer, release paper and a first color developing layer; and the second color developing assembly comprises a glove anda second color developing layer. According to the invention, through the arrangement of the first color developing layer, a patient can conveniently place the hand at the upper part of the first colordeveloping layer, and in the injection process, radiopharmaceutical 18F-FDG drips on the first color developing assembly, and the first color developing layer is used for developing color; the side part of the glove is coated with the second color developing layer, and the 18F-FDG drips on the glove for color development, so that the contaminated part can be conveniently marked or the glove can be conveniently replaced in time, the subsequent cleaning is facilitated, and the secondary contamination is avoided.

Description

technical field [0001] The invention relates to the technical field of medical appliances, more specifically, it relates to a radionuclide operating table capable of displaying radioactive pollution. Background technique [0002] 18F-FDG (fluorodeoxyglucose, referred to as FDG) is currently the most commonly used imaging agent for PET (positron emission tomography) / CT (X-ray tomography) imaging. A dose of the radioactive drug is given intravenously into the patient. Generally, the patient puts his hand on the operating table, uses the gloves installed by the doctor to hold the syringe, and injects the extracted radioactive drug into the patient's body intravenously. [0003] During the injection process, even standard operations will inevitably cause radioactive contamination such as drug dripping. Because FDG is colorless and odorless, during operation, the operator often cannot find out in time after dripping occurs, and may continue to operate with polluted hands to cau...

AI Technical Summary

Problems solved by technology

Because FDG is colorless and odorless, during operation, the operator often cannot find out in time after dripping occurs, and may continue to operate with polluted hands to cause secondary pollution in other places, or the polluted countertop is not replaced in time and further pollutes the next one. A patient's arm, affecting the effect of radioactivity detection of subsequent patients

[0004] At present, after the imaging agent and drug-related operations, surface radioactive contamination detectors are often used to measure whether the operating table or the hands of the operator are contaminated, but this is an after-the-fact detection, which cannot be detected in time and effectively handled during the operation, and is time-consuming and laborious.

FDG is an analogue of glucose, it will react with potassium iodide and turn blue, but potassium iodide is volatile, potentially dangerous and inconvenient to use

Images